1. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine (NEJM). 343 (10); 682-688. September 7, 2000.
2. Simon JA, Mazer NA, Wekselman K. Safety profile: transdermal testosterone treatment of women after oophorectomy. Obstetrics & Gynecology. 97 (4); S10-1. 2001.
3. Simon JA. Emerging treatment strategies for hypoactive sexual desire disorder in postmenopausal women. Supplement to Contemporary OB/GYN: Restoring sexual desire: the safety and efficacy of testosterone in menopausal women. 18-23. September 2004.
4. Simon JA, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder: results of the intimate SM1 Study. Journal of Clinical Endocrinology and Metabolism (JECM). 90 (9); 5226-5233. 2005.
5. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Archives of Internal Medicine. 165 (14); 1582-1589. July 25, 2005.
6. Shifren JL, Davis SR, Dennerstein L, Heiman JR, Lobo RA, Simon JA. The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society (NAMS). Menopause. 12 (5); 497-511. November 2005.
7. Simon JA. The role of testosterone in the treatment of hypoactive sexual desire disorder in postmenopausal women. Menopause Management. 14 (6); 6-11. November-December 2005.
8. Traish A, Guay A, Spark F, Simon JA, the Testosterone Therapy in Women Study Group. Are the Endocrine Society’s clinical practice guidelines on androgen therapy in women misguided? A commentary. Journal of Sexual Medicine. 4 (5); 1223-1235. September 2007.
9. Abdallah RT, Simon JA. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder. International Journal of Impotence Research. 19 (5); 458–463. Review. September-October 2007.
10. Traish A, Guay AT, Spark RF, and the Testosterone Therapy in Women Study Group. Are the Endocrine Society’s Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary. Journal of Sexual Medicine. 4 (6); 1782-1783. November 2007.
11. Simon J, Snabes MC. Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen. Expert Opinion on Investigational Drugs. December 2007; 16 (12); 2005-2020. Review.
12. Kingsberg SA, Simon, JA, Goldstein, I. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Journal of Sexual Medicine. 5 (Supplement 4); 182-193; quiz 193. Review. 2008.
13. Hubayter Z, Simon JA. Testosterone therapy for sexual dysfunction in postmenopausal women. Climacteric. 11 (3); 181-191. Review. May 2008.
14. Krapf JM and Simon JA. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas. Epub May 31, 2009. Review. 63 (3); 213-219. July 20, 2009.
15. Zarek SM and Simon JA. Testosterone: Transdermal versus oral testosterone. British Journal of Sexual Medicine. 33 (2); 8-10. 2010.
16. Nachtigall L, Casson P, Lucas J, Schofield V, Melson C, and Simon JA. Safety and tolerabililty of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Gynecological Endocrinology. 27 (1); 39-48. January 2011.
17. Krapf JM and Simon JA. A Gender-Specific Dose-Response Curve for Testosterone: Could Excessive Testosterone Limit Sexual Interaction in Women? Journal of Sexual Medicine. 8; 76. April, 2011.
18. Goldstein I, Kim NN, Clayton AH, DeRogatis LR, Giraldi A, Parish SJ, Pfaus J, Simon JA, Kingsberg SA, Meston C, Stahl SM, Wallen K, Worsley R. Hypoactive Sexual Desire Disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clinical Proceedings. EPub December 1, 2016.
19. Clayton AH, Goldstein I, Kim NN, Althof SE, Faubion SS, Faught BM, Parish SJ, Simon JA, Vignozzi L, Christiansen K, Davis SR, Freedman MA, Kingsberg SA, Kirana PS, Larkin L, McCabe, M, Sadovsky R. Process of Care Mayo Clinic Proceedings. The International Society for the Study of Women’s Sexual Health (ISSWSH) Process of Care for Management of Hypoactive Sexual Desire Disorder in Women. Mayo Clinic Proceedings. 93 (4); 467-487.
20. Simon JA, Davis SR, Althof SE, Chedraui P, Clayton AH, Kingsberg SA, Nappi RE, Parish SJ, Wolfman W. Sexual well-being after menopause: An International Menopause Society White Paper. Climacteric. 2018 Oct;21(5):415-427.
21. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Sexual Medicine, 16 (9); 1331-1337.
22. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. (2019) Global Consensus Position Statement on the Use of Testosterone Therapy for Women, Journal of Clinical Endocrinology and Metabolism. EPub September 2019. 104 (10) DOI: 10.1210/jc.2019-01603. 104 (10); 4660-4666. October 1, 2019.
23. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Maturitas, Epub September 2, 2019. 128; 89-93.
24. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women, Climacteric, 22 (5); 429-434, DOI: 10.1080/13697137.2019.1637079, Epub September 2, 2019. Correction: DOI: 10.1080/13697137.2019.1673555. 22 (6); 637. October 15, 2019.
25. Rowen TS, Davis SR, Parish S, Simon J, Vignozzi L. Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women. The Journal of Sexual Medicine. 17(4); 585-594. February 13, 2020.
26. Simon JA & Kapner MD. The Saga of Testosterone for Menopausal Women at the Food and Drug Administration (FDA). The Journal of Sexual. Medicine. 17(4); 826-829. April 1, 2020.
27. Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Climacteric: The Journal of Adult Women’s Health and Medicine. 24(6); 533-550. April 1, 2021.
28. Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. The Journal of Sexual Medicine. 18(5); 849-867. April 1, 2021.
29. Marko KI, Simon JA. Androgen therapy for women after menopause. Best Practice & Research Clinical Endocrinology & Metabolism. 35 (6); 101592. December 2021.
30. Laing AJ, Newson L, Simon J. Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development. The Cancer Journal. 28(3); 196-203. May 6, 2022.

BOOKS, CHAPTERS, PROCEEDINGS AND INVITED ARTICLES:

1. Simon J, Houston V. Restore Yourself: A Woman’s Guide to Reviving Her Sexual Desire and Passion for Life. New York, NY. Berkley Publishing Group/ Penguin Putnam, Inc. December 2001.
2. Simon J. Pharmaceutical Treatment Options for the Female Androgen Insufficiency Syndrome. Handout for the NAMS CME Symposium. San Diego, CA. September 2005.
3. Wise EA, Mack CJ, Simon JA. Sexual Dysfunction and Androgen Replacement Therapy. Management of the Perimenopause (Liu JH and Gass MLS, eds). McGraw-Hill Companies, Inc., New York, 355-376. 2006.
4. Simon, JA. Androgen Therapy After Menopause: Sex, Bone, Brawn, Breast, and Brain. A Rountable Discussion. 20th Annual Meeting of the North American Menopause Society (NAMS). San Diego, CA. October 2, 2009.
5. Villaseca P, Simon JA. Androgenos En Climaterio y Menopausia en el Siglo XXI [Translated: Female Sexual Dysfunction and Testosterone therapy: Essentials for Gynecologists.] Capitulo VIII; 257-261 ISBN 978-956-7992-11-9. 2011.
6. Simon JA. A patient requests your advice about testosterone from a compounding pharmacy to supplement her hormone therapy. How should you advise her? Are there any guidelines for dosing testosterone ordered from these pharmacies? Menopause e-Consult. 9 (1); 1-2. January 2013.
7. Pollycove R, Simon, J. Female Sexual Dysfunction and Testosterone Therapy: Essentials for Gynecologists. Androgens in Gynecological Practice: Managing the Basics. Leo Plouffe, Jr. MD and Botros Rizk, MD (eds), Cambridge University Press, 38-54. 2015.
8. Streicher, L., Simon, J.A. (2018). Sexual Function Post-Breast Cancer. In: Gradishar, W. (eds) Optimizing Breast Cancer Management. Cancer Treatment and Research, vol 173. Springer, Cham.
9. Rubin RS, Simon JA. Genitourinary Syndrome of Menopause: The Role of Estrogens and Androgens. Female Sexual Pain Disorders, Volume 2; (Goldstein AT, et al, eds.), John Wiley & Sons Ltd., 251-259. 2021.
10. Karram M, Glaser R, Simon J, Streicher L. Testosterone supplementation in women: When, why, and how. A Supplement to OBG Management. 33(3); 32-38. March 2021.
11. 11. Rowen TS, Simon JA. Sexual Dysfunction in the Female. Female Reproduction. Volume 2; Chapter 128. pp 2124-2134. In: Robertson, R. Paul, ed. DeGroot’s endocrinology: basic science and clinical practice. Elsevier Health Sciences, 2022.
12. 12. Rowen TS, Simon JA. Sexual Desire and Pharmacologic Management. Obstet Gynecol Clin North Am. 2024 Jun;51(2):259-271.